Key indicators: single-crystal X-ray study; T = 173 K; mean (C-C) = 0.003 Å; disorder in main residue; R factor = 0.048; wR factor = 0.136; data-to-parameter ratio = 9.0.
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For biological properties of pyrazole derivatives, see : Hall et al. (2008) ; Isloor et al. (2009) ; Patel et al. (2010) ; Samshuddin et al. (2010) . For the chemistry of aminopyrazoles, see: Giuseppe et al. (1991) . For the medicinal activity of pyrazoles, see : Vinogradov et al. (1994) . For related structures, see: Dobson & Gerkin (1998) ; Foces-Foces et al. (1996) ; Hemamalini & Fun (2010) ; Thanigaimani et al. (2012) . For hydrogen-bond graphset motifs, see: Bernstein et al. (1995) . For standard bond lengths, see: Allen et al. (1987) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
Data collection: CrysAlis PRO (Agilent, 2012 ); cell refinement: CrysAlis PRO; data reduction: CrysAlis RED (Agilent, 2012); program(s) used to solve structure: SUPERFLIP (Palatinus & Chapuis, 2007 ); program(s) used to refine structure: SHELXL2012 (Sheldrick, 2008) ; molecular graphics: OLEX2 (Dolomanov et al., 2009) ; software used to prepare material for publication: OLEX2.
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Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: LH5637). Pyrazoles are an important class of heterocyclic compounds and many pyrazole derivatives are reported to have a broad spectrum of biological properties, e.g. antibacterial and anti-inflammatory activities (Patel et al., 2010) , anticancer (Hall et al., 2008) , antimicrobial (Samshuddin et al., 2010) , anti-inflammatory, antidepressant, anticonvulsant and anti-HIV properties (Isloor et al., 2009) . The chemistry of aminopyrazoles has been extensively investigated in the past (Giuseppe et al., 1991) . The considerable biological and medicinal activities of pyrazoles (Vinogradov et al., 1994) for which aminopyrazoles are preferred precursors, have stimulated our investigations.
The crystal structures of some related compounds, viz., 3-aminopyrazole-4-carboxylic acid (Dobson & Gerkin, 1998) , 4-(3,5-dimethylpyrazol-1-yl)benzoic acid trifluoroacetate (Foces-Foces et al., 1996) , 2-amino-5-methylpyridinium trifluoroacetate (Thanigaimani et al., 2012) and 2-amino-5-chloropyridinium trifluoroacetate (Hemamalini & Fun, 2010) have been reported. In view of the importance of the title compound this paper reports its crystal structure.
The asymmetric unit of the title compound consists of two crystallographically independent 3-aminopyrazolium cations (A and B) and two trifluoroacetate anions (A and B) (Fig. 1) . Each 3-aminopyrazolium cation is planar, with a maximum deviation of 0.0006 (2) Å for atom N2A in cation A and 0.0005 (2) Å for atom N2B in cation B. In the cations, atoms N3A and N3B are protonated. The F atoms of both anions are disordered over two sets of positions, with occupancy ratios of 0.639 (12):0.361 (12). Bond lengths and are normal (Allen et al., 1987) .
In the crystal packing ( (Bernstein et al., 1995) ring motifs.
A mixture of commercially available 3-aminopyrazole and trifluoroacetic acid (1:3 v/v) were stirred for 15 minutes at room temperature. X-ray quality crystals were formed on slow evaporation. (m.p.: 463-468 K).
Refinement
All H atoms were located in a difference Fourier map and refined independently with isotropic displacement parameters 
Computing details
Data collection: CrysAlis PRO (Agilent, 2012 ); cell refinement: CrysAlis PRO (Agilent, 2012) ; data reduction: CrysAlis RED (Agilent, 2012 ); program(s) used to solve structure: SUPERFLIP (Palatinus & Chapuis, 2007 ); program(s) used to refine structure: SHELXL2012 (Sheldrick, 2008) ; molecular graphics: OLEX2 (Dolomanov et al., 2009) ; software used to prepare material for publication: OLEX2 (Dolomanov et al., 2009 The asymmetric unit of the title compound. Displacement ellipsoids are drawn at the 30% probability level. All disorder components are shown. Special details Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (

